News & Events
Featured
News
- Press ReleaseJune 10, 2026
Goodwin Advises Pharmakon Advisors on Intellectual Property Aspects for CHF 250 Million ($310 Million USD) Loan to Idorsia Pharmaceuticals Ltd
- Press ReleaseJune 10, 2026
Innovafeed is Scaling Up and Entering a New Growth Phase Backed by a €51 Million Funding Round
- Press ReleaseJune 9, 2026
Goodwin Advises Nurix Therapeutics on Global Collaboration With Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg for $700 Million Upfront and Up to $2.3 Billion in Total
- Press ReleaseJune 8, 2026
Goodwin Strengthens Life Sciences Public M&A Bench With Partner Richard Schwartz
Events
- Speaking EngagementsJune 25, 2026
AI on the Docket: How AI is Transforming the Practice of Antitrust Law
- Speaking EngagementsJune 17, 2026
Federal Circuit Bar Association’s 2026 Bench & Bar Conference
- Speaking EngagementsJune 16, 2026
Getting Ahead of What’s Next: What Today’s Regulation, Disclosure Trends, and AI Mean for Public Companies
- WebinarJune 10, 2026
Hikma v. Amarin: What the Supreme Court's Decision Means for Skinny Labeling and Induced Infringement
Media Contact
Email
press@goodwinlaw.com
Phone
United States: +1 617 570 1500
Europe: +44 20 7447 4240
Asia: +852 3658 5305